Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 703

1.

Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.

Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N.

Immunol Lett. 2005 Jul 15;99(2):180-5. Epub 2005 Mar 17.

PMID:
16009268
2.

Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).

Takeda H, Kawasaki E, Shimizu I, Konoue E, Fujiyama M, Murao S, Tanaka K, Mori K, Tarumi Y, Seto I, Fujii Y, Kato K, Kondo S, Takada Y, Kitsuki N, Kaino Y, Kida K, Hashimoto N, Yamane Y, Yamawaki T, Onuma H, Nishimiya T, Osawa H, Saito Y, Makino H; Ehime Study.

Diabetes Care. 2002 Jun;25(6):995-1001.

PMID:
12032105
3.

The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes.

Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B.

Eur J Immunogenet. 2003 Jun;30(3):223-7.

PMID:
12787001
4.

HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes.

Cerna M, Novota P, Kolostova K, Cejkova P, Zdarsky E, Novakova D, Kucera P, Novak J, Andel M.

Eur J Immunogenet. 2003 Dec;30(6):401-7.

PMID:
14675393
5.

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissén M, Ehrnström BO, Forsén B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC.

Diabetes. 1999 Jan;48(1):150-7.

PMID:
9892237
6.

Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.

Sugihara S, Sakamaki T, Konda S, Murata A, Wataki K, Kobayashi Y, Minamitani K, Miyamoto S, Sasaki N, Niimi H.

Diabetes. 1997 Nov;46(11):1893-7.

PMID:
9356042
7.

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.

Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R.

Diabetologia. 1999 May;42(5):608-16.

PMID:
10333055
8.

Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes.

Hamaguchi K, Kimura A, Kusuda Y, Yamashita T, Yasunami M, Takahasi M, Abe N, Yoshimatsu H.

Diabetes Res Clin Pract. 2004 Nov;66(2):163-71.

PMID:
15533584
9.

HLA typing and immunological characterization of young-onset diabetes mellitus in a Hong Kong Chinese population.

Kelly MA, Chan JC, Heward J, Mijovic CH, Zimmet PZ, Yeung VT, Cockram C, Barnett AH.

Diabet Med. 2001 Jan;18(1):22-8.

PMID:
11168337
10.

[Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].

Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L.

Orv Hetil. 2001 Nov 18;142(46):2571-8. Hungarian.

PMID:
11770176
11.

[Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].

Hermann R, Gombos Z, Gyürüs E, Soltész G.

Orv Hetil. 2003 Feb 23;144(8):355-60. Hungarian.

PMID:
12666382
12.

Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.

Stayoussef M, Benmansour J, Al-Jenaidi FA, Said HB, Rayana CB, Mahjoub T, Almawi WY.

Clin Vaccine Immunol. 2011 Jun;18(6):990-3. doi: 10.1128/CVI.00073-11. Epub 2011 Apr 13.

13.

HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.

Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E.

Int J Immunogenet. 2008 Apr;35(2):133-40. doi: 10.1111/j.1744-313X.2008.00749.x. Epub 2008 Feb 11.

PMID:
18279373
14.

High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.

Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Bazzigaluppi E, Dotta F, Bosi E; Non Insulin Requiring Autoimmune Diabetes Study Group.

Diabetes Care. 2007 Apr;30(4):932-8.

PMID:
17392553
15.

Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?

Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U.

Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):8-14.

PMID:
10707033
16.

HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients.

Serjeantson SW, Court J, Mackay IR, Matheson B, Rowley MJ, Tuomi T, Wilson JD, Zimmet P.

Hum Immunol. 1993 Oct;38(2):97-104.

PMID:
8106272
17.

Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.

Wang JP, Zhou ZG, Lin J, Huang G, Zhang C, Yang L, Yuan Y, Zhou HF, Zhou M, Hou C, Zhou WD, Peng H, Hagopian WA.

Tissue Antigens. 2007 Nov;70(5):369-75.

PMID:
17919266
18.

Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.

Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA.

Diabet Med. 1994 Apr;11(3):299-303.

PMID:
8033530
19.

Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.

Antonelli A, Tuomi T, Nannipieri M, Fallahi P, Nesti C, Okamoto H, Groop L, Ferrannini E.

Diabetologia. 2002 Sep;45(9):1298-306. Epub 2002 Jul 24.

PMID:
12242463
20.

HLA-associated cellular response to GAD in type 2 diabetes with antibodies to GAD.

Fukui M, Nakamura N, Nakano K, Kajiyama S, Matsuo S, Obayashi H, Ohta M, Shigeta M, Shigeta H, Kitagawa Y, Kondo M.

Endocr J. 2000 Dec;47(6):753-61.

Supplemental Content

Support Center